Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Clinical Drug Investigation|May 23, 2007
Steady-state pharmacokinetics of pravastatin in children with familial hypercholesterolaemiaHeleen E Wiersma, Albert Wiegman, Richard P Koopmans, et al.
Medical Teacher|September 1, 2012
Reflective learning in a patient safety course for final-year medical studentsJeantine M de Feijter, Willem S de Grave, Esther M Hopmans, et al.
Intensive Care Medicine|October 18, 2006
Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosingCatherine S C Bouman, Hendrikus J M van Kan, Richard P Koopmans, et al.
American Journal of Hypertension|November 22, 2008
Are RGS2 gene polymorphisms associated with high blood pressure in an ethnicity- and gender-specific manner?Ines N Hahntow, Gideon Mairuhu, Irene G M van Valkengoed, et al.
BMJ Open|September 3, 2017
<i>Labtracker+</i>, a medical smartphone app for the interpretation of consecutive laboratory results: an external validation studyJudith M Hilderink, Roger J M W Rennenberg, Floris H M Vanmolkot, et al.
British Journal of Clinical Pharmacology|July 28, 2006
In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugsMarie L De Bruin, Pim N J Langendijk, Richard P Koopmans, et al.
Circulation|October 7, 2004
Impaired cerebral autoregulation in patients with malignant hypertensionRogier V Immink, Bert-Jan H van den Born, Gert A van Montfrans, et al.
Clinical Pharmacokinetics|May 23, 2013
Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patientsPetra C van Rijn-Bikker, Oliver Ackaert, Nelleke Snelder, et al.
American Journal of Hypertension|September 26, 2009
Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial populationPetra C van Rijn-Bikker, Gideon Mairuhu, Gert A van Montfrans, et al.
Pageof 4